• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New Pituitary Adenoma Classification System to Individualise Management and Improve Long-Term Prognosis.

作者信息

Johannsson Gudmundur, Ragnarsson Oskar, Skoglund Thomas

机构信息

Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

出版信息

Clin Endocrinol (Oxf). 2025 Feb;102(2):147-148. doi: 10.1111/cen.15170. Epub 2024 Nov 27.

DOI:10.1111/cen.15170
PMID:39601375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694552/
Abstract
摘要

相似文献

1
New Pituitary Adenoma Classification System to Individualise Management and Improve Long-Term Prognosis.新的垂体腺瘤分类系统用于个体化管理并改善长期预后。
Clin Endocrinol (Oxf). 2025 Feb;102(2):147-148. doi: 10.1111/cen.15170. Epub 2024 Nov 27.
2
Pituitary adenomas: biology, nomenclature and clinical classification.垂体腺瘤：生物学、命名法及临床分类
Rev Endocr Metab Disord. 2025 Apr;26(2):137-146. doi: 10.1007/s11154-025-09944-x. Epub 2025 Jan 25.
3
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis.一种用于指导垂体肿瘤治疗和预后的临床分类建议。
Lancet Diabetes Endocrinol. 2024 Mar;12(3):209-214. doi: 10.1016/S2213-8587(23)00382-0. Epub 2024 Jan 29.
4
The 2017 WHO classification of pituitary adenoma: overview and comments.2017 年世界卫生组织垂体腺瘤分类：概述与评论。
Brain Tumor Pathol. 2018 Apr;35(2):51-56. doi: 10.1007/s10014-018-0314-3. Epub 2018 Apr 23.
5
Overview of the 2017 WHO Classification of Pituitary Tumors.《2017 年世界卫生组织垂体肿瘤分类概述》。
Endocr Pathol. 2017 Sep;28(3):228-243. doi: 10.1007/s12022-017-9498-z.
6
Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective.垂体腺瘤或垂体神经内分泌肿瘤：争议与展望的叙述性综述
Transl Cancer Res. 2021 Apr;10(4):1916-1920. doi: 10.21037/tcr-20-3446.
7
Impact of histopathological classification of non-functioning adenomas on long term outcomes: comparison of the 2004 and 2017 WHO classifications.非功能性腺瘤的组织病理学分类对长期预后的影响：2004 年和 2017 年 WHO 分类的比较。
Pituitary. 2022 Dec;25(6):988-996. doi: 10.1007/s11102-022-01281-5. Epub 2022 Oct 19.
8
Newer Concepts in the Classification of Pituitary Adenomas.垂体腺瘤分类的新概念。
Neurol India. 2020 May-Jun;68(Supplement):S7-S12. doi: 10.4103/0028-3886.287667.
9
Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.内镜经鼻入路切除巨大垂体腺瘤:205 例患者的临床结果，并比较两种术前预测肿瘤全切除程度的分类系统。
J Neurosurg. 2021 Sep 17;136(3):786-800. doi: 10.3171/2021.3.JNS204116. Print 2022 Mar 1.
10
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.内分泌疾病的管理：垂体肿瘤的临床病理分类和分子标志物，用于制定个体化治疗策略。
Eur J Endocrinol. 2014 Mar 13;170(4):R121-32. doi: 10.1530/EJE-13-1031. Print 2014 Apr.

本文引用的文献

1
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis.一种用于指导垂体肿瘤治疗和预后的临床分类建议。
Lancet Diabetes Endocrinol. 2024 Mar;12(3):209-214. doi: 10.1016/S2213-8587(23)00382-0. Epub 2024 Jan 29.
2
Proteomic Profiles Associated With Postsurgical Progression in Nonfunctioning Pituitary Adenomas.与无功能性垂体腺瘤术后进展相关的蛋白质组学特征。
J Clin Endocrinol Metab. 2024 May 17;109(6):1485-1493. doi: 10.1210/clinem/dgad767.
3
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.垂体腺瘤或神经内分泌肿瘤：综合预后分类的必要性。
Nat Rev Endocrinol. 2023 Nov;19(11):671-678. doi: 10.1038/s41574-023-00883-8. Epub 2023 Aug 17.
4
Healthcare cost and survival in patients with non-functioning pituitary adenoma.非功能性垂体腺瘤患者的医疗费用与生存情况。
Eur J Endocrinol. 2023 Jun 7;188(6):477-484. doi: 10.1093/ejendo/lvad057.
5
Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives.2022 年世界卫生组织垂体腺瘤/垂体神经内分泌肿瘤分类概述：临床实践、争议和观点。
Curr Med Sci. 2022 Dec;42(6):1111-1118. doi: 10.1007/s11596-022-2673-6. Epub 2022 Dec 22.
6
Real-life clinical impact of a five-tiered classification of pituitary tumors.垂体瘤五级分类的现实临床影响。
Eur J Endocrinol. 2022 Nov 29;187(6):893-904. doi: 10.1530/EJE-22-0812. Print 2022 Dec 1.
7
Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly.糖尿病对肢端肥大症患者发病率和死亡率的影响。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):2483-2492. doi: 10.1210/clinem/dgac400.
8
Clinical Biology of the Pituitary Adenoma.垂体腺瘤的临床生物学。
Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010.
9
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.库欣病患者的总体死亡率和疾病特异性死亡率：一项瑞典全国性研究。
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2375-2384. doi: 10.1210/jc.2018-02524.
10
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification.垂体神经内分泌肿瘤的复发风险：采用五级分类的前瞻性研究。
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3368-3374. doi: 10.1210/jc.2017-00773.